La Clinica terapeutica
1984-10-31
[Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
C Sfrisi, G Cocco
Index: Clin. Ter. 111(2) , 159-67, (1984)
Full Text: HTML
Abstract
Related Articles:
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.
2006-08-01
[J. Biomol. Screen. 11(5) , 457-68, (2006)]
Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
2000-10-01
[J. Mol. Cell. Cardiol. 32(10) , 1831-40, (2000)]
Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways.
2000-04-01
[Urol. Res. 28(2) , 110-5, (2000)]
HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.
1982-11-08
[Life Sci. 31 , 2037, (1982)]
Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
1987-07-01
[Chest 92(1) , 118-23, (1987)]